TYPE2DIABETES
Clinical trials for TYPE2DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE2DIABETES trials appear
Sign up with your email to follow new studies for TYPE2DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes device gets second chance for control group
Disease control Not yet recruitingThis study offers a medical device treatment to people with type 2 diabetes who were in the placebo group of a previous trial. It aims to collect real-world safety and performance data on the Endogenex System, which is designed to help control blood sugar. The study will enroll a…
Matched conditions: TYPE2DIABETES
Phase: NA • Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Free groceries fight diabetes: new program aims to stop disease before it starts
Prevention Not yet recruitingThis study is testing if a diabetes prevention program that also provides free fruits and vegetables works better than the standard program alone. It will enroll 100 adults at risk for type 2 diabetes who face challenges like food insecurity. The goal is to see if this combined a…
Matched conditions: TYPE2DIABETES
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC
-
Scientists probe genetic link to diabetes inside the pancreas
Knowledge-focused Not yet recruitingThis study aims to understand how a specific gene variant, known to increase the risk of type 2 diabetes, affects the function of insulin-producing cells in the pancreas. Researchers will compare 80 people with different versions of this gene by measuring their blood sugar and ho…
Matched conditions: TYPE2DIABETES
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Diabetes device registry launches to track 5-Year patient outcomes
Knowledge-focused Not yet recruitingThis registry aims to collect long-term safety and health outcome information from people with type 2 diabetes who have already been treated with the Endogenex System. It will follow up to 500 participants for five years to monitor their health after the procedure. The goal is to…
Matched conditions: TYPE2DIABETES
Sponsor: Endogenex, Inc. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC